1
|
Haile SR, Jeong JH, Chen X, Cheng Y. A 3-parameter Gompertz distribution for survival data with competing risks, with an application to breast cancer data. J Appl Stat 2016. [DOI: 10.1080/02664763.2015.1134450] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- S. R. Haile
- Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland
| | - J.-H. Jeong
- Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA
| | - X. Chen
- Department of Statistics, University of Pittsburgh, Pittsburgh, PA, USA
| | - Y. Cheng
- Department of Statistics, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
| |
Collapse
|
2
|
Putora PM, Engeler D, Haile SR, Graf N, Buchauer K, Schmid HP, Plasswilm L. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients. Strahlenther Onkol 2015; 192:182-9. [PMID: 26713323 DOI: 10.1007/s00066-015-0928-x] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2015] [Accepted: 11/20/2015] [Indexed: 12/31/2022]
Abstract
BACKGROUND AND PURPOSE For localized prostate cancer, treatment options include external beam radiotherapy (EBRT), radical prostatectomy (RP), and brachytherapy (BT). Erectile dysfunction (ED) is a common side-effect. Our aim was to evaluate penile erectile function (EF) before and after BT, EBRT, or RP using a validated self-administered quality-of-life survey from a prospective registry. MATERIAL AND METHODS Analysis included 478 patients undergoing RP (n = 252), EBRT (n = 91), and BT (n = 135) with at least 1 year of follow-up and EF documented using IIEF-5 scores at baseline, 6 weeks, 6 months, 1 year, and annually thereafter. RESULTS Differences among treatments were most pronounced among patients with no or mild initial ED (IIEF-5 ≥ 17). Overall, corrected for baseline EF and age, BT was associated with higher IIEF-5 scores than RP (+ 7.8 IIEF-5 score) or EBRT (+ 3.1 IIEF-5 score). EBRT was associated with better IIEF-5 scores than RP (+ 4.7 IIEF-5 score). In patients undergoing EBRT or RP with bilateral nerve sparing (NS), recovery of EF was observed and during follow-up, the differences to BT were not statistically significant. Overall age had a negative impact on EF preservation (corrected for baseline IIEF). CONCLUSION In our series, EF was adversely affected by each treatment modality. Considered overall, BT provided the best EF preservation in comparison to EBRT or RP.
Collapse
Affiliation(s)
- P M Putora
- Department of Radiation Oncology, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland
| | - D Engeler
- Department of Urology, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland
| | - S R Haile
- Clinical Trials Unit, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland
| | - N Graf
- Clinical Trials Unit, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland
| | - K Buchauer
- Department of Radiation Oncology, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland
| | - H P Schmid
- Department of Urology, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland
| | - L Plasswilm
- Department of Radiation Oncology, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland.
| |
Collapse
|
3
|
Abstract
BACKGROUND Anterior cervical spine surgery is a common procedure for fusions and/or discectomies. Postoperative dysphonia and dysphagia are known complications. In this study, we examined the frequency and outcomes of these complications in this patient population. MATERIALS AND METHODS Patients planned to receive anterior cervical spine surgery between 01.03.2010 and 28.02.2011 at the Department of Neurosurgery, St. Gallen were prospectively included. Patients were evaluated using laryngoscopy, fiberoptic endoscopic evaluation of swallowing (FEES), voice field measurements and validated questionnaires. RESULTS From the 53 patients included in the study, 40 had at least one complete follow-up examination. The frequency of postoperative dysphonia due to recurrent nerve palsy was 4/40 (10 %), although this was temporary in 3 patients. FEES revealed a pathological result in 18.9 % of patients. Postoperative Swallowing Quality of Life Questionnaire (Swal-QoL) scores were significantly lower. CONCLUSION At a frequency of 10 %, dysphonia due to recurrent nerve palsy is a relevant complication in cervical spine surgery, albeit temporary in most cases. Postoperative dysphagia is common and should be evaluated and treated during follow-up.
Collapse
Affiliation(s)
- R Mukherjee
- Hals-Nasen-Ohrenklinik, Kantonsspital St. Gallen, 9007, St. Gallen, Schweiz
| | | | | | | | | | | | | |
Collapse
|
4
|
Rothermundt C, Whelan JS, Dileo P, Strauss SJ, Coleman J, Briggs TW, Haile SR, Seddon BM. What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. Br J Cancer 2014; 110:2420-6. [PMID: 24736584 PMCID: PMC4021531 DOI: 10.1038/bjc.2014.200] [Citation(s) in RCA: 65] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2014] [Revised: 03/13/2014] [Accepted: 03/20/2014] [Indexed: 11/23/2022] Open
Abstract
Background: There are neither prospective data nor agreement on the optimal routine follow-up procedures in patients treated for soft tissue sarcoma of the limb. Methods: Data on 174 consecutive patients with a soft tissue sarcoma of the limb undergoing follow-up by oncologists at a single centre from 2003 to 2009 were included in this analysis. The rate and site of recurrence and mode of detection were analysed. Outcome of the patients was assessed. Results: Eighty-two patients (47%) experienced relapse of any type. Isolated local recurrence occurred in 26 patients and local relapse with synchronous pulmonary metastases in five patients. Local recurrences were detected clinically in 30 of these 31 patients; magnetic resonance imaging identified only one local recurrence. Twenty-eight patients developed isolated lung metastases; in nine patients these were amenable to resections, seven of whom are currently free of disease after treatment. Lung metastases were detected by chest x-ray (CXR) in 19 patients, computed tomography scanning in 3 patients, and clinically in 11 patients. Twenty-three patients developed non-pulmonary metastases. More than 80% of relapses occurred in the first 2 years of follow-up; however, later recurrences were also observed. Conclusions: Routine follow-up CXR can detect lung metastases suitable for surgical resection, although the optimal interval of imaging has yet to be defined. Local relapse is almost always detected by patients or physicians, and routine scanning of the primary site is of doubtful benefit. Patient and physician education to detect local relapse may be helpful. Prospective evaluation of follow-up is recommended.
Collapse
Affiliation(s)
- C Rothermundt
- Division of Oncology/Haematology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland
| | - J S Whelan
- London Sarcoma Service, University College London Hospitals, London NW1 2BU, UK
| | - P Dileo
- London Sarcoma Service, University College London Hospitals, London NW1 2BU, UK
| | - S J Strauss
- London Sarcoma Service, University College London Hospitals, London NW1 2BU, UK
| | - J Coleman
- Department of Orthopaedic Surgery, Royal National Orthopaedic Hospital, Middlesex HA7 4LP, UK
| | - T W Briggs
- Department of Orthopaedic Surgery, Royal National Orthopaedic Hospital, Middlesex HA7 4LP, UK
| | - S R Haile
- Clinical Trials Unit, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland
| | - B M Seddon
- London Sarcoma Service, University College London Hospitals, London NW1 2BU, UK
| |
Collapse
|
5
|
Lövin N, Fischer T, Haile SR, Drack G, Hornung R. Geburtseinleitung mit einem Wehen-Cocktail im Vergleich zu Dinoproston-Depotpräparat und oral appliziertem Misoprostol. Z Geburtshilfe Neonatol 2011. [DOI: 10.1055/s-0031-1293400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
6
|
Strasser F, Oberholzer R, Blum D, Joerger M, Driessen C, deWolf-Linder S, Haile SR, von Moos R, Zerkiebel N, Jatoi A, Woelky R, Fearon K, Cerny T. Lenalidomide in solid tumor patients with inflammatory cancer cachexia: A multicenter, randomized, double-blind, proof-of-concept study of fixed dose or CRP-response-guided dose or placebo. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.tps239] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
7
|
Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases. Ann Surg Oncol 2011; 18:1924-31. [PMID: 21207165 DOI: 10.1245/s10434-010-1505-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2010] [Indexed: 01/01/2023]
Abstract
BACKGROUND An outcome assessment was performed of patients with unresectable colorectal liver metastases (CRLM) treated in second or third line with floxuridine (FUDR)-based hepatic artery infusion (HAI). METHODS Twenty-three patients who were pretreated with systemic (immuno)chemotherapy received FUDR-HAI alone or combined with systemic chemotherapy. We reviewed patient charts and our prospective patient database for survival and associated risk factors. RESULTS Patients received FUDR-HAI for unresectable CRLM from January 2000 to September 2010. Twelve patients (52%) received concurrent systemic chemotherapy. Median overall survival (OS), progression-free survival (PFS), and hepatic PFS were 15.6 months (range, 2.5-55.7 months), 3.9 months (range, 0.7-55.7 months), and 5.5 months (range, 1.6-55.7 months), respectively. The liver resection rate after HAI was 35%. PFS was better in patients undergoing secondary resection than in patients without resection (hazard ratio [HR] 0.21; 95% confidence interval [95% CI] 0.07-0.66; P = 0.0034), while OS showed a trend toward improvement (HR 0.4; 95% CI 0.13-1.2; P = 0.09). No differences were observed in OS (P = 0.69) or PFS (P = 0.086) in patients who received FUDR-HAI alone compared with patients treated with combined regional and systemic chemotherapy. No statistically significant differences were seen in patients previously treated with one chemotherapy line compared with patients treated with two lines. Presence of extrahepatic disease was a negative risk factor for PFS (liver-only disease: HR 0.03; 95% CI 0.0032-0.28; P < 0.0001). Toxicities were manageable with dose modifications and supportive measures. CONCLUSIONS FUDR-HAI improves PFS and results in a trend toward improved OS in selected patients able to undergo liver resection after tumor is downsized.
Collapse
Affiliation(s)
- Panagiotis Samaras
- Department of Oncology and Surgery, University Hospital Zurich, Zurich, Switzerland
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Land SR, Kopec JA, Lee M, Haile SR, Ritter MW, Krag D, Anderson SJ, Ganz PA, Wolmark N. Quality of life in breast cancer patients receiving sentinel-node (SN) biopsy alone or with axillary dissection (AD): Results from NSABP Protocol B-32. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.9533] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|